Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

  • Giuseppina Rosaria Rita Ricciardi,
  • Barbara Adamo,
  • Antonio Ieni,
  • Luana Licata,
  • Roberta Cardia,
  • Giuseppa Ferraro,
  • Tindara Franchina,
  • Giovanni Tuccari,
  • Vincenzo Adamo
  • Article
  • Metrics
  • Comments
  • Media Coverage

There are a number of errors in the caption of Fig 1. Please see the complete, correct Fig 1 caption here.

thumbnail
Download:
Fig 1. The E-cadherin, Ki-67 and AR expression in 45 patients TNBC.

Legend: [A, B] E-cadherin negative/positive staining; [C,D] Ki-67 level < or ≥ 20%; [E,F] negative/positive AR staining.

https://doi.org/10.1371/journal.pone.0132647.g001

Reference

  1. 1. Ricciardi GRR, Adamo B, Ieni A, Licata L, Cardia R, Ferraro G, et al. (2015) Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS ONE 10(6): e0128368. pmid:26039245

Citation: Ricciardi GRR, Adamo B, Ieni A, Licata L, Cardia R, Ferraro G, et al. (2015) Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS ONE 10(7): e0132647. https://doi.org/10.1371/journal.pone.0132647

Published: July 2, 2015

Copyright: © 2015 Ricciardi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited